RJ
James, Richard William
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Sphingosine‐1‐phosphate as a key player of insulin secretion induced by high‐density lipoprotein treatment | Physiological reports | 2021 | 251 | 138 | |||
| HDL protects against myocardial ischemia reperfusion injury via miR-34b and miR-337 expression which requires STAT3 | PLOS ONE | 2019 | 288 | 177 | |||
| High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate | European Journal of Clinical Investigation | 2018 | 496 | 0 | |||
| Differential Association of Cx37 and Cx40 Genetic Variants in Atrial Fibrillation with and without Underlying Structural Heart Disease | International Journal of Molecular Sciences | 2018 | 611 | 224 | |||
| Pharmacological Intervention to Modulate HDL: What Do We Target? | Frontiers in Pharmacology | 2017 | 490 | 383 | |||
| Self-Observation and Peer Feedback as a Faculty Development Approach for Problem-Based Learning Tutors: A Program Evaluation | Teaching and learning in medicine | 2017 | 710 | 864 | |||
| Impaired stimulation of glucose transport in cardiac myocytes exposed to very low-density lipoproteins | NMCD. Nutrition Metabolism and Cardiovascular Diseases | 2016 | 527 | 3 | |||
| Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43 | Cardiovascular research | 2016 | 694 | 6 | |||
| Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection | Arteriosclerosis, Thrombosis, and Vascular Biology | 2016 | 615 | 1 | |||
| Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury | PloS one | 2015 | 664 | 245 | |||
| Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signaling | Immunity, inflammation and disease | 2015 | 1,188 | 186 | |||
| CD14 as a Mediator of the Mineralocorticoid Receptor-Dependent Anti-apolipoprotein A-1 IgG Chronotropic Effect on Cardiomyocytes | Endocrinology | 2015 | 664 | 1 | |||
| Modulating reconstituted high density lipoprotein functionality to target the Pseudomonas aeruginosa quorum sensing system | Life sciences | 2014 | 622 | 0 | |||
| Serum paraoxonase-1 activity is more closely related to HDL particle concentration and large HDL particles than to HDL cholesterol in Type 2 diabetic and non-diabetic subjects | Clinical biochemistry | 2014 | 487 | 0 | |||
| High density lipoproteins and ischemia reperfusion injury: the therapeutic potential of HDL to modulate cell survival pathways | Advances in experimental medicine and biology | 2014 | 548 | 0 | |||
| HDL protects against ischemia reperfusion injury by preserving mitochondrial integrity | Atherosclerosis | 2013 | 548 | 0 | |||
| HDLs protect pancreatic β-cells against ER stress by restoring protein folding and trafficking | Diabetes | 2012 | 634 | 0 | |||
| Lack of association between connexin40 polymorphisms and coronary artery disease | Atherosclerosis | 2012 | 592 | 5 | |||
| The natural cardioprotective particle HDL modulates connexin43 gap junction channels | Cardiovascular research | 2012 | 673 | 4 | |||
| Lipid-Induced Modulation of Protective Signalling Pathways in Cardiovascular Disease: The Role of High Density Lipoproteins | Current signal transduction therapy | 2012 | 567 | 0 | |||
| High density lipoprotein/sphingosine-1-phosphate-induced cardioprotection: Role of STAT3 as part of the SAFE pathway | JAK-STAT | 2012 | 610 | 337 | |||
| Consistency between cross-sectional and longitudinal SNP: blood lipid associations | European journal of epidemiology | 2012 | 653 | 326 | |||
| The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro | British journal of pharmacology | 2012 | 587 | 0 | |||
| Antiapolipoprotein A-1 IgG chronotropic effects require nongenomic action of aldosterone on L-type calcium channels | Endocrinology | 2012 | 706 | 0 | |||
| Relationship between paraoxonase-1 activity, its Q192R genetic variant and clopidogrel responsiveness in the ADRIE study | Journal of thrombosis and haemostasis | 2011 | 632 | 0 | |||
| When are pro-inflammatory cytokines SAFE in heart failure? | European heart journal | 2011 | 594 | 0 | |||
| HDL-associated paraoxonase-1 can redistribute to cell membranes and influence sensitivity to oxidative stress | Free radical biology & medicine | 2011 | 684 | 625 | |||
| Paraoxonase-1 and clopidogrel efficacy | Nature medicine | 2011 | 505 | 0 | |||
| Effects of paraoxonase activity and gene polymorphism on coronary vasomotion | EJNMMI research | 2011 | 562 | 293 | |||
| The scavenger receptor class B, type I is a primary determinant of paraoxonase-1 association with high-density lipoproteins | Arteriosclerosis, thrombosis, and vascular biology | 2010 | 580 | 0 | |||
| The contribution of high density lipoprotein apolipoproteins and derivatives to serum paraoxonase-1 activity and function | Advances in experimental medicine and biology | 2010 | 604 | 0 | |||
| Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis | Cardiovascular research | 2010 | 589 | 0 | |||
| Serum lipoproteins attenuate macrophage activation and Toll-Like Receptor stimulation by bacterial lipoproteins | BMC immunology | 2010 | 596 | 502 | |||
| Expression of the hepatic Niemann-Pick C1 like 1 protein gene is sensitive to rosuvastatin treatment of primary human hepatocytes | Pharmacogenetics and genomics | 2010 | 603 | 0 | |||
| Macrophage migration inhibitory factor deficiency leads to age-dependent impairment of glucose homeostasis in mice | Journal of Endocrinology | 2010 | 920 | 0 | |||
| Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction | European heart journal | 2010 | 701 | 0 | |||
| Myeloperoxidase and paraoxonase-1 in type 2 diabetic patients | NMCD. Nutrition Metabolism and Cardiovascular Diseases | 2009 | 634 | 0 | |||
| Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate | Cardiovascular research | 2009 | 555 | 0 | |||
| Dietary phytoestrogens activate AMP-activated protein kinase with improvement in lipid and glucose metabolism | Diabetes | 2008 | 710 | 1 | |||
| Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome | Clinical science | 2008 | 764 | 9 | |||
| Paraoxonase 1: genetics and activities during aging | Rejuvenation research | 2008 | 602 | 0 | |||
| HDL subfraction distribution of paraoxonase-1 and its relevance to enzyme activity and resistance to oxidative stress | Journal of lipid research | 2008 | 557 | 0 | |||
| Do allelic variants of the connexin37 1019 gene polymorphism differentially predict for coronary artery disease and myocardial infarction? | Atherosclerosis | 2007 | 630 | 0 | |||
| In a quasi-simultaneous assessment, imprecise cholesterol monitoring and screening tests were improved | Journal of Clinical Epidemiology | 2005 | 143 | 0 | |||
| Presence of autoantibodies to apolipoprotein A-1 in patients with acute coronary syndrome further links autoimmunity to cardiovascular disease | Journal of autoimmunity | 2004 | 538 | 0 | |||
| Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice | Circulation | 2003 | 559 | 1 | |||
| Angiotensin II promotes selective uptake of high density lipoprotein cholesterol esters in bovine adrenal glomerulosa and human adrenocortical carcinoma cells through induction of scavenger receptor class B type I | Endocrinology | 2001 | 699 | 441 | |||
| From biopsy to automatic diagnosis | Schweizerische medizinische Wochenschrift | 1990 | 554 | 0 |
